April 22, 2020

AACR 2020 preview – no Tigit, but plenty of novel mechanisms

Next week’s virtual meeting could resuscitate Ox40 agonists, but an important omission will disappoint.

September 28, 2018

The rollercoaster ride continues for China’s cell therapy sector

Companies like Nanjing Legend and Cellular Biomedicine Group continue to attract major financial endorsement from Western big pharma, but the threat of scandal is…

July 28, 2017

Upcoming events – FDA approvals due for Maviret and Besponsa

January 10, 2017

JP Morgan – Kite feeds Eastern CAR-T promise

April 08, 2016

Juno looks east

March 31, 2015

Daily  Market Movers (30 Mar 2015)

February 11, 2015

A move to roll up China’s cell therapy market